STEPHANIE BURRIS: Open Payments
NPI 1659749992 · OGLETHORPE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,218 in 166 payments from 21 companies in 2025. Trend: 2023 $2,738 · 2024 $2,994 · 2025 $3,218
Food & beverage: $3,158Education: $60
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 41 | $824 |
| Amgen Inc. | 20 | $405 |
| Janssen Biotech, Inc. | 15 | $404 |
| UCB, Inc. | 20 | $367 |
| Aurinia Pharma U.S., Inc. | 17 | $226 |
| GlaxoSmithKline, LLC. | 9 | $170 |
| AstraZeneca Pharmaceuticals LP | 10 | $149 |
| Novartis Pharmaceuticals Corporation | 8 | $140 |
| PFIZER INC. | 8 | $140 |
| GENZYME CORPORATION | 4 | $88 |
Products named: RINVOQ, TREMFYA, Bimzelx, LUPKYNIS, BENLYSTA, OTEZLA, SAPHNELO, COSENTYX.
Industry payments across GA — which companies pay providers there.
